ClinicalTrials.Veeva

Menu

Mitochondrial Function in Circulating Cells and Muscle Tissue (MitoWomen)

University of Arkansas logo

University of Arkansas

Status

Completed

Conditions

Healthy
Obesity
Women
Insulin Sensitivity

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The main goal of this project is to determine whether mitochondrial function in circulating cells is related to that measured in the muscle fibers of the same subjects.

Full description

Data from human and animal models strongly suggests that reduced tissue mitochondrial function can be an early marker for detection of dysfunctional metabolism. It is unclear if tissue mitochondrial dysfunction can be detected using less invasive methodology. In this project, the investigators plan to study mitochondrial bioenergetics in circulating cells and paired muscle biopsies in two metabolic disparate groups of women; healthy lean vs. overweight/obese with/without insulin resistant women of similar age. Women of similar age that are either healthy lean or overweight/obese with/without insulin resistance will be recruited to participate in one study that includes a blood draw and a muscle biopsy. Mitochondrial function in circulating blood cells and muscle tissue will be determined. The association between circulating blood cells and muscle tissue mitochondria respiration will be determined for the two groups combined, and differences between groups will also be investigated.

Enrollment

35 patients

Sex

Female

Ages

25 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Women
  • 25-35 years of age
  • Either healthy lean (BMI<25) or insulin resistant and obese (BMI >30)

Exclusion criteria

  • Medication that can affect study outcomes, as determined by the principal investigator, including anti-diabetic medication
  • Chronic diseases, acute inflammation, chronic renal failure (glomerular filtration rate <45), or heart problems

Trial design

35 participants in 2 patient groups

Healthy lean
Description:
Healthy lean women, 25-35 years
Overweight/obese with/without IR
Description:
Overweight/obese with/without insulin resistant women, 25-35 years

Trial documents
2

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems